Objective-Arterial calcification is considered a major cause of death and disabilities worldwide because the associated vascular remodeling leads to myocardial infarction, stroke, aneurysm, and pulmonary embolism. This process occurs via poorly understood mechanisms involving a variety of cell types, intracellular mediators, and extracellular cues within the vascular wall. An inverse correlation between endothelial primary cilia and vascular calcified areas has been described although the signaling mechanisms involved remain unknown. We aim to investigate the signaling pathways regulated by the primary cilium that modulate the contribution of endothelial cells to vascular calcification. Approach and Results-We found that human and murine endothelial cells lacking primary cilia are prone to undergo mineralization in response to bone morphogenetic proteins stimulation in vitro. Using the Tg737 orpk/orpk cillium-defective mouse model, we show that nonciliated aortic endothelial cells acquire the ability to transdifferentiate into mineralizing osteogenic cells, in a bone morphogenetic protein-dependent manner. We identify β-CATENIN-induced SLUG as a key transcription factor controlling this process. Moreover, we show that the endothelial expression of SLUG is restricted to atheroprone areas in the aorta of LDLR −/− mice. Finally, we demonstrate that SLUG and phospho-homolog of the Drosophila protein, mothers against decapentaplegic (MAD) and the Caenorhabditis elegans protein SMA (from gene sma for small body size)-1/5/8 expression increases in endothelial cells constituting the vasa vasorum in the human aorta during the progression toward atherosclerosis. Conclusions-We demonstrated that the lack of primary cilia sensitizes the endothelium to undergo bone morphogenetic protein-dependent-osteogenic differentiation. These data emphasize the role of the endothelial cells on the vascular calcification and uncovers SLUG as a key target in atherosclerosis. (Arterioscler Thromb Vasc Biol. 2015;35:616-627. The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
A s a common result of atherosclerosis or metabolic disorders (ie, diabetes mellitus and renal disease), vascular calcification constitutes a major health problem worldwide. 1 Although the biomedical understanding of this disease has increased during the past years, the underlying molecular mechanisms need to be uncovered to develop novel effective approaches for its intervention.
To date it is well accepted that calcification of the atherosclerotic plaque occurs via mechanisms resembling the process of bone mineralization. 2, 3 This process, which mainly affects the intima layer, involves cross-talk between different cell types (osteoblast-like cells, vascular smooth muscle cells, pericytes, endothelial cells [ECs], inflammatory cells, etc), secreted cytokines, and growth factors, such the bone morphogenetic proteins (BMPs). 1 Interestingly, elevated expression levels of BMPs have been found in sites of vascular calcification, 4,5 thereby promoting an osteogenic-like environment in the vascular wall. The BMP ligands (BMP-2/4, BMP-5/6/7/8, GDF-5/6/7 and BMP-9/10) signal via 2 types of serine/threonine kinase receptors, 6, 7 leading to the phosphorylation of homologs of the Drosophila protein, mothers against decapentaplegic (MAD) and the Caenorhabditis elegans protein SMA (from gene sma for small body size) (SMAD)-1/5/8, which associate with the common mediator SMAD (ie, SMAD4). SMAD complexes accumulate in the nucleus and regulate the expression of specific target genes, including osteogenic factors. 8, 9 Emerging evidence suggest that the osteogenic signals initiated in the tunica adventitia are transmitted to the calcifying tunica media via the vasa vasorum, 10, 11 promoting the recruitment of smooth muscle actin-positive cells. In the intima layer, these cells produce extracellular matrix molecules, including interstitial collagen, and form the calcified plaque. It has been recently proposed that ECs contribute to vascular calcification via a dedifferentiation process known as endothelial-to-mesenchymal transition (EndoMT), resulting in osteogenic cells. [12] [13] [14] [15] [16] In mice, it was reported that EndoMT leads to ≥10% of the smooth muscle cells in the neointima and affects ≤80% of luminal ECs. EndoMT is thought to be executed by a subset of transcription factors (including SLUG) [17] [18] [19] [20] potently regulated by inflammatory cytokines, 21 WNT, 22 NOTCH, 23 and members of the transforming growth factor-β (TGF-β) superfamily, [24] [25] [26] including the BMPs.
Despite a variety of systemic risk factors that have been suggested, the distribution of calcified lesions probably reflects differing hemodynamics along the vasculature.
In mice, plaques accumulate in the inner curvature of the aorta, at the intersections with other vessels (carotid and subclavian arteries) and the aortic side of the semilunar valves, 27 where ECs are under disturbed flow. Interestingly, accumulation of ECs expressing primary cilia has been reported at the boundaries of the plaques, [28] [29] [30] whereas ECs under shear stress (like in the outer curve of the aorta or on top of the atheroma) rapidly disassemble them. 31 The endothelial primary cillium acts as a mechanosensor that allows the cell to respond more efficiently to environmental changes. [32] [33] [34] [35] It consists of a protrusion composed of a 9+0 bundle core of microtubule doublets that extends throughout the cell membrane into the extracellular space and binds to the cytoskeleton via the basal body. 36 Its presence in vascular ECs has been extensively reported 31, [37] [38] [39] and recently it has been shown that it regulates EndoMT during cardiogenesis. 40 The oak ridge polycystic kidney (ORPK) mouse model 41 consists of the genetic disruption of the expression and function of the intraflagellar transport homolog 88 (Ift88, Tg737, and Polaris) gene, impairing the proper assembling of motile and nonmotile cilia. Interestingly, as other mice models defective in primary cilia, the oak ridge polycystic kidney mice exhibit vascular disorders such as aneurysm. 42 In this study, we demonstrate that human and murine ECs lacking primary cilia are sensitized to undergo BMPinduced osteogenic differentiation. Using ECs isolated from the oak ridge polycystic kidney mice, we show that BMP activity is necessary to undergo this process, which is mediated by SLUG. Disruption of the primary cillium increased β-CATENIN, which is a critical determinant in the upregulation of the transcription factor Slug mRNA levels. Moreover, we show that SLUG expression in the aorta of LDLR −/− mice is restricted to atheroprone areas and correlates with a loss of the endothelial marker PECAM-1. Finally, we demonstrate that the endothelial expression of SLUG in the vasa vasorum of the human aorta increases at the early stages of atherosclerosis, in parallel with phospho-SMAD1/5/8 activity. Therefore, we conclude that primary cilia contribute to maintain the stability of the endothelium and prevent SLUG mediated-vascular calcification.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. Sample collection and handling were performed in accordance with the guidelines of the Medical and Ethical Committee in Leiden, Netherlands, and the code of conduct of the Dutch Federation of Biomedical Scientific Societies.
Results

ECs Lacking Primary Cilia Are Prone to BMP-Induced Mineralization
ECs have been shown to dedifferentiate into mesenchymallike cells eventually leading to osteogenic cells. The efficiency of this mechanism depends on a plethora of factors (organism, source, growth factors, etc). As we have previously reported that ECs lacking primary cilia tend to undergo flow-induced EndoMT, 40 we hypothesized that primary cilia may influence the ability of ECs to differentiate into osteoblast-like cells, as a further consequence of undergoing EndoMT in a BMP-rich context. To test our hypothesis, we stimulated human umbilical vein ECs isolated from different donors to undergo BMPinduced osteoblast differentiation.
We detected calcium deposits using alizarin red solution (ARS) staining in those human umbilical vein ECs characterized by a lower number of primary cilia, as indicated by acetylated α-TUBULIN staining ( Figure 1A-1C ). Moreover, the mouse EC lines MS-1, mouse embryonic ECs (MEEC), and 2H-11 and the bovine aortic ECs BAEC lacking primary cilia were strongly stained with ARS in response to BMP-6 ( Figure 1D-1F ). Interestingly, the mouse aortic ECs (MECs) with a high number of cells assembling primary cilia, as shown by acetylated α-TUBULIN staining, were poorly differentiated into osteogenic cells. In contrast, MECs isolated from the primary cilium defective Orpk −/− mice (Tg737 orpk/orpk ) were highly responsive to BMP-6-induced mineralization. These data suggest that primary cilia influence the mineralizing response of ECs to BMP ligands in human and mice.
BMP Activity Is Necessary for Nonciliated ECs to Undergo Mineralization
To investigate how the primary cillium affects the BMP calcifying response of ECs, we compared MECs from wildtype and Orpk −/− mice. As indicated by alkaline phosphatase (ALP) staining ( Figure 2A ) and enzymatic assay ( Figure IIA in the online-only Data Supplement), as well as ARS staining ( Figure 2B ; Figure IIB in the online-only Data Supplement), Tg737 orpk/orpk MECs underwent osteogenic differentiation in response to BMPs, whereas wild-type MECs did not express ALP or mineralized. Moreover, BMP-6 was the most potent ligand-inducing osteogenic differentiation of Tg737 orpk/orpk MECs, which correlated with a more sustained SMAD1/5/8 phosphorylation ( Figure 2C ). Using the SMAD1-SMAD4dependent transcriptional luciferase reporter plasmid, BRE-LUC, we determined that BMP/SMAD signaling induced by BMP-6 was not enhanced in nonciliated MECs, and the BMP Figure 2D ). Similarly, SMAD1/5/8 was equally phosphorylated in response to 1-hour stimulation with BMP-6 ( Figure 2E ).
According to previous reports, 43 Tg737 orpk/orpk cells exhibited a higher basal phosphorylation of SMAD2. To investigate whether TGF-β signaling is responsible for the mineralizing phenotype of Tg737 orpk/orpk cells, we cultured these cells in the staining was performed after 21 days incubation in osteogenic medium (OM) containing BMP-6 (50 ng/mL). Growth medium (GM) is shown as negative staining control. C, Calcium deposits were solubilized and quantified by absorbance. The graph represents average and SD from 3 independent experiments. D (left) and E, Detection and quantification of primary cilia were performed on murine MS-1, mouse embryonic ECs (MEEC), 2H-11, mouse aortic ECs (MECs) wild-type and Tg737 orpk/orpk, and bovine aortic endothelial cells (BAEC) as described above. D, right, to detect cellular mineralization, ARS staining was performed after incubation of the cells 2 weeks in OM containing BMP-6 (50 ng/mL). Growth medium is shown as staining control. F, Calcium precipitates were solubilized and quantified by absorbance. The graph shows average and SD from 3 independent experiments. Willebrand growth factor (vwf; ***P<0.0001), and Pecam-1 (*P=0.0246 and **P=0.0002), were quantified by quantitative polymerase chain reaction. Average of 3 independent assays ±SD is shown. C, Wild-type, Tg737 orpk/orpk , and Tg737 o/o -ift88 MECs were stained for acetylated α-TUBULIN to detect the primary cillium (white arrows). As previously indicated, the overexpression of IFT88 is sufficient to reassemble the primary cillium. Moreover, the knockdown of ift88 was performed in wild-type MECs (sh ift88 1 and sh ift88 2), which resulted in a reduction in the number of cells expressing primary cilia. D, ALP activity was measured in wild-type MECs and ift88 knocked-down cells (**P=0.0014 and ***P<0.0001) and after stimulated for 1 week with BMP-6 (50 ng/mL; **P=0.0002 and **P=0.0040). E, Representative ARS pictures of wild-type MECs stably transduced with empty shRNA vectors, as well as 2 constructs targeting mouse ift88, stimulated with BMP-6 (50 ng/mL).
presence of the activin receptor-like kinase-4/5/7 kinase inhibitor SB-431542 or BMP type I receptor kinase inhibitor LDN-193189 for 5 days followed by BMP-6 or TGF-β stimulation for 2 weeks. Western blotting confirmed that SMAD1/5/8 and SMAD2 phosphorylation were effectively inhibited by LDN-193189 and SB-431542, respectively ( Figure 2F ). ARS staining showed that, although BMP type I receptor inhibition mitigates Tg737 orpk/orpk MECs mineralization, TGF-β type I receptor kinase activity is dispensable ( Figure 2G ; Figure IIC in the online-only Data Supplement). These findings suggest that BMP/SMAD signaling, but not TGF-β/SMAD signaling is required for the calcification of Tg737 orpk/orpk MECs.
Next the specific role of the primary cillium disruption in MECs was studied. Tg737 orpk/orpk MECs stably overexpressing IFT88 (Tg737 o/o -ift88 MECs) resembled the wild-type nonmineralizing phenotype in response to BMP-6 ( Figure 3A) , as analyzed by ALP, ARS, and von Kossa stainings. Moreover, Tg737 o/o -ift88 MECs rescued the assembling of primary cilia ( Figure 3C ). Furthermore, quantitative polymerase chain reaction analysis showed that Tg737 o/o -ift88 MECs resembled the wild-type phenotype characterized by low expression of the osteogenic genes Runx2, Col1α and Bsp, and high expression of the EC markers Ve-cadherin, Von Willebrand factor (vwf), and Pecam-1 ( Figure 3B ) compared with nonciliated Tg737 orpk/orpk cells. Finally, increased ALP activity ( Figure 3D ) and mineralizing activity ( Figure 3E ; Figure IIIA in the online-only Data Supplement) was observed in and ift88 stably knockdown MECs in response to BMP-6. These results demonstrate an increased sensitivity of MECs lacking primary cillium to undergo BMP-mediated osteogenic differentiation.
Transcription Factor SLUG Mediates the BMP-Induced Cell Mineralization in Embryonic MECs Lacking Primary Cilia
To investigate the mechanism involved in the osteogenic differentiation of nonciliated ECs in response to BMPs, we analyzed the mRNA expression of the epithelial-to-mesenchymal transition markers Slug, Snail, Twist, and Sip-1 ( Figure 4A ). We found that all of them were significantly upregulated in nonciliated Tg737 orpk/orpk MECs in comparison with wildtype and Tg737 o/o -ift88 MECs. Particularly, Slug mRNA was nearly absent in wild-type MECs and dramatically induced in mutant nonciliated MECs. This observation was confirmed at the protein level by Western blotting and immunofluorescent labeling using a SLUG specific antibody ( Figure 4B and 4C). Furthermore, stable ift88 knockdown cells increased the expression of SLUG ( Figure IIIB in the online-only Data Supplement). Noteworthy, BMP-6 further enhanced Slug expression specifically in Tg737 orpk/orpk MECs ( Figure 4D ).
To demonstrate the involvement of SLUG in BMP-6induced calcification of MEC Tg737 orpk/orpk cells, we obtained stably knocked-down Slug cells ( Figure IIIC in the onlineonly Data Supplement) and observed that their ability to mineralize in response to BMP-6 ( Figure 4E ; Figure IIID in the online-only Data Supplement) was impaired. Moreover, ectopic expression of SLUG in wild-type MECs ( Figure 4F ) increased the endogenous expression of the osteogenic markers RunX2 ( Figure 4G ) and Osterix (Osx; Figure 4H ), as well as the ALP activity of wild-type MECs ( Figure 4I ). Finally, by cotransfection assays, we found that SLUG overexpression directly upregulated the transcription of the luciferase reporters Collagen-1-α ( Figure IIIE) and Osteopontin ( Figure IIIF in the online-only Data Supplement). Taken together, these results demonstrate that loss of the primary cillium promotes calcification of MECs in a SLUG-dependent manner.
Increased Expression of β-CATENIN in Nonciliated MECs Contributes to Upregulate SLUG Expression
It has been demonstrated that many signaling pathways (including WNT) contribute to vascular calcification although the cross talk pathways remain unknown. To decipher the mechanism by which the primary cillium modulates the expression of SLUG, we compared the expression of β-CATENIN between wild-type and Tg737 orpk/orpk MECs.
As Figure 5A and 5B shows, nonciliated MECs displayed a higher cytosolic and nuclear β-CATENIN expression, which coincides with increased SLUG expression. Moreover, increased expression of β-CATENIN was also observed in ift88 knockdown cells ( Figure IIIB in the online-only Data Supplement). We found that Tg737 orpk/orpk MECs activated more potently the TCF4/β-CATENIN reporter construct (BAT-LUC; Figure 5C ), as well as the Slug promotor luciferase reporter plasmid ( Figure 5D ), which is consistent with our previous results ( Figure 4A ). In addition, cotransfection of a dominant negative TCF4∆N expression vector, which disrupts the TCF4/ β-CATENIN interaction, reduced the reporter activity in nonciliated cells ( Figure 5E ), whereas wild-type TCF4 increased it. Furthermore, we showed that siRNAmediated transient knockdown of β-CATENIN in Tg737 orpk/orpk MECs downregulated the SLUG-LUC reporter plasmid activity ( Figure 5F ), as well as BMP-6-induced ALP activity ( Figure 5G and 5H ). All together, our findings demonstrate that disruption of the primary CILLIUM in MECs provokes high expression of β-CATENIN, inducing the transcription of Slug. These results suggest that primary cilia may act as signaling complexes to integrate β-CATENIN and BMP signal transduction pathways in MECs to regulate their osteogenic differentiation.
SLUG Expression Is Associated With Atherogenic Regions in Mice and Humans
Recently, an active role of the endothelium on the formation of the atherosclerotic plaque and the calcification of the vessels has been demonstrated. 12, 16 To investigate whether the absence of primary cilia sensitizes the endothelium to an SLUG-dependent transformation and later calcification, we studied the aorta of LDLR −/− mice fed with a Westerntype diet for 20 weeks. This treatment leads to neointima formation and allows us to investigate whether SLUG contributes to the dedifferentiation of ECs before calcification.
Immunofluorescent analysis on paraffin sections (n=3) using antibodies against PECAM-1 and acetylated α-TUBULIN allowed us to identify areas undergoing neointima formation (atheroprone area), as well as nonaffected areas of the endothelium ( Figure 6A ). We detected PECAM-1 and primary cilia in nonaffected areas along the aorta (Figure 6B ), whereas they were nearly absent in atheroprone areas ( Figure 6C and 6D) . Moreover, immunohistochemical analysis on consecutive sections revealed that SLUG was expressed in clusters of ECs lining the neointima (Figure 6C ), whereas it was absent in healthy endothelium ( Figure 6B and 6E) , thus supporting our in vitro results. Next, we studied the aorta of human specimens during the progression of atherosclerosis. Using immunofluorescent labeling to stain sections of human atherosclerostic aortae ( Figure 6F ), we detected luminal ECs assembling primary cilia ( Figure 6G) , in contrast to ECs constituting the vasa vasorum, where no primary cilia were visible ( Figure 6H) . Interestingly, invasion of the human aorta by microcapillaries has been correlated in time with the formation of the plaque and the recruitment of mesenchymal-like cells to the necrotic core. 44, 45 Therefore, according to our in vitro results, ECs in the vasa vasorum may be sensitized to BMP-induced osteogenic differentiation. Interestingly, these capillaries have shown to provide the atherosclerotic site with mesenchymal-like cells with osteogenic potential in humans. 46, 47 To determine whether and SLUG (green channel) on wild-type and Tg737 orpk/orpk MECs. Nuclei were stained with DAPI (blue channel). C, BAT-LUC reporter assay on wild-type and Tg737 orpk/orpk MECs. BAT-LUC activity was normalized using the TCF4-defective Fop-flash plasmid (**P=0.006). Average of ≥3 independent assays ±SD is shown. D, Slug promotor-luciferase reporter assay comparing the transcriptional activity in wild-type and Tg737 orpk/orpk MECs (***P=0.0002). Average of ≥3 independent assays ±SD is shown. E, Cotransfection of Slug-LUC with a TCF4 expressing vector or a dominant negative counterpart (TCF4ΔN), in Tg737 orpk/orpk MECs (*P<0.0235 and ***P<0.0027). Average of ≥3 independent assays ±SD is shown. F, Tg737 orpk/orpk MECs were cotransfected with siRNAs targeting β-catenin or scrambled siRNAs, in the presence of the Slug reporter gene (***P<0.001), and luciferase activity was quantified. Average of ≥3 independent assays ±SD is shown. G, Tg737 orpk/orpk MECs were transfected with siRNAs targeting β-catenin or scrambled siRNAs, stimulated with BMP-6 (50 ng/mL) and stained for alkaline phosphatase (ALP). A representative picture is shown. H, Tg737 orpk/orpk MECs were transfected with siRNAs targeting β-catenin or scrambled siRNAs, stimulated with BMP-6 (50 ng/mL) and lysates were used in ALP enzymatic assay (***P<0.001). Average of ≥3 independent assays ±SD is shown.
ECs constituting the vasa vasorum may act as a source of mesenchymal-like cells through EndoMT, we stained paraffin sections from the aortae of healthy donors (ie, without signs of atherosclerosis), as well as early fibroatheroma and fibrotic calcified plaques (n=4) specimens, according to the classification proposed by Virmani et al, 48 using antibodies for phospho-SMAD1/5/8 and SLUG (Figure 6I and 6J ). Semiquantitative analysis revealed increased SLUG expression in ECs at the early stages of the atheroma formation (early fibroatheroma; Figure 6K ), before vessel calcification. A similar pattern was followed by phospho-SMAD1/5/8 staining ( Figure 6L ), which indicated that active BMP signaling is occurring in these particular ECs. These findings support our in vitro data and the fact that BMPs induce osteogenic differentiation in nonciliated ECs in a SLUG-dependent manner.
Discussion
In this study, we demonstrated that lack of primary cilia primes human and murine ECs to undergo a BMP-dependentosteogenic differentiation. In vitro we showed that the absence of cilia leads to an increase in the expression of EndoMT mediators and, in particular, SLUG. Moreover, we showed that the primary cillium modulates the expression of β-CATENIN, which regulates the transcription of Slug. Furthermore, we confirmed our findings in an in vivo model using LDLR −/− mice and showed that SLUG is expressed in the regions of the aorta undergoing neointima formation, where PECAM-1-positive cells and primary cilia are not detected. Finally, we demonstrated that the expression of SLUG and phospho-SMAD1/5/8 in ECs from the vasa vasorum in the human aorta is increased during the progression of atherosclerosis, suggesting that our findings may also occur in a pathological context. These data highlight the physiological importance of the primary cillium mediating the cross-talk between TGF-β/ BMP and β-CATENIN signaling pathways in vascular calcification and highlights SLUG as a possible therapeutic target.
We have shown that the calcifying phenotype of human and murine ECs in response to BMPs is tightly determined by the presence of the primary cillium. To date, it is considered that the expression of the primary cillium is affected by shear stress, which induces EndoMT in nonciliated MECs via a mechanism dependent on activin receptor-like kinase-5 signaling. Nevertheless, in our report, preincubation of the Tg737 orpk/orpk cells with an activin receptor-like kinase-4/5 inhibitor failed to abolish the BMP-triggered calcification of MECs, whereas treatment with a BMP type I receptor kinase inhibitor completely blocked the mineralization. These results underline BMP signaling as an ultimate regulator of endothelial mineralization and, indeed, are consistent with the development of BMP inhibitors to block vascular calcification, 49 rather than fibroblast growth factor and TGF-β inhibitors, 50,51 which may interfere with early EndoMT and not with calcification itself. Moreover, investigating other mechanisms (for example, in addition to shear stress or inflammation) that regulate the expression and function of the primary cillium might contribute not only to identify new cardiovascular risk factors but also to find new druggable targets to prevent arterial calcification.
Importantly, despite the fact that the Tg737 orpk/orpk cells may have undergone a dedifferentiation process during the early development of the mice, the restoration of the primary cillium by overexpressing ift88 rescued the wild-type phenotype. Moreover, the stable knockdown of ift88 in wild-type cells could partially mimic the Tg737 orpk/orpk cells phenotype, characterized by high SLUG and β-CATENIN expression, together with the ability to mineralize in response to BMPs. Although the ift88 knockdown efficiency was considerable, still some ciliated cells could be observed in the cultures, which results in a heterogeneous population, probably less sensitive to BMP-induced mineralization than the Tg737 orpk/orpk cell culture.
Previous reports have proven the direct participation of ECs in the neointima formation using lineage tracing. 16, 52 To gain insights into the mechanisms regulating this process, we found that the expression of primary cilia in the aorta of Westerntype diet fed LDLR −/− mice was restricted to nonaffected areas, characterized by PECAM-1-expressing ECs. On the contrary, primary cilia or PECAM-1 were not observed in ECs at SLUGpositive regions, suggesting a loss of the endothelial phenotype. In accordance with this, Tg737 orpk/orpk MECs expressed low levels of endothelial markers (including Pecam-1) and they were increased in ciliated wild-type and Tg737 o/o -ift88 MECs.
As it has been indicated elsewhere, experimental atherosclerosis in animal models does not mimic the human condition entirely. 45 In particular, mice do not exhibit resident smooth muscle cells in the intima layer, whereas human atheroprone regions contain a considerable population of these cells. Moreover, during human atherogenesis, a massive population of smooth muscle actin-positive cells migrate through the vasa vasorum into the intima, where they proliferate and differentiate into osteogenic cells in response to growth factors. To investigate whether the ECs from the vasa vasorum themselves may contribute to this osteoprogenitor population, we demonstrated that SLUG is nearly absent in healthy individuals and its expression in the ECs from the vasa vasorum increases at the early stages of the atheroma formation, following the same expression pattern as phospho-SMAD1/5/8. Because primary cilia were not detected in capillary ECs, our findings suggest that the expression of SLUG in ECs forming the vasa vasorum is highly sensitive to BMP stimulation and supports the role of capillaries as suppliers of cells with an osteogenic potential. Therefore, our results contribute to uncover the exact origin of mesenchymal-like cells in vivo in the context of human pathologies associated to vascular calcification.
In summary, we propose a model ( Figure I in the onlineonly Data Supplement) where BMP signaling activation is necessary, but not sufficient, to induce the transdifferentiation of ECs into osteoblast-like cells. The osteogenic effect of BMPs is dramatically enhanced in the absence of the endothelial primary cilia. This mechanism is strongly dependent on the transcription factor SLUG, which promotes the secretion of a bone matrix and leads to the calcification and destruction of the vessel. An interesting area of future research will be to analyze whether inhibition of BMP or WNT signaling, as well as direct targeting of SLUG, in animal models limits the vascular calcification in the atherosclerotic plaque.
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